"The Virus may never go away", WHO says. This could be endemic.
Reuters article
As most of us may have heard, the COVID-19 caused bu SARS-CoV2 has already started mutating according to research scientists. An excerpt from an article below.
MSB's stem cell research and cure will be here to stay for years to come. The more Virus variants we encounter, the greater the need for companies like MSB to remain at the forefront of the game, whether it is dealing with issues on hand or anticipating potential diseases of the future and gearing up resources to plan and implement solutions that may address these issues universally. Nevertheless, MSB is here to stay. COVID-19 is a thing of now, but this company is geared up for the future.
Forget about the stock price movement that we see today or tomorrow, I am extremely pleased to see a company I am invested in having a massive global presence. I know this when I hear about MSB from people who are overseas telling me that they heard about an Aussie company in the running.....It just makes me feel proud to be a part of this, in an inconsequential way, but still a part of it.
SOMETIMES IT MAKES SENSE TO TAKE A MOMENT TO SALUTE A COMPANY THAT IS WE ARE PRIVILEGED TO BE A PART OF, STOP BAGGING IT.
PROUDLY AUSTRALIAN!!!
==========================================================================================================
- Every virus mutates; it’s part of the virus life cycle. Those shifts and changes aren’t always a big deal.
- The new coronavirus is an RNA virus: a collection of genetic material packed inside a protein shell.
- RNA viruses, like the flu and measles, are more prone to changes and mutations compared with DNA viruses, such as herpes, smallpox, and human papillomavirus (HPV).
As the new coronavirus SARS-CoV-2 makes its way around the world, there’s been an uptick in predictions that the virus will mutate into something deadlier and become an even scarier threat to humanity.
“Mutation. The word naturally conjures fears of unexpected and freakish changes,” researchers wrote in a reportTrusted Source published in Nature Microbiology in late February. “Ill-informed discussions of mutations thrive during virus outbreaks,” they continued, which is exactly what we’re seeing with SARS-CoV-2.
But mutations aren’t necessarily a bad thing. Every virus mutates; it’s part of the virus life cycle. Those shifts and changes aren’t always a big deal.
In some cases, those mutations may actually lead to a weaker virus. Usually, though, the changes are so slight that there’s no noticeable difference in the disease’s transmission and fatality rates.
The new coronavirus is an RNA virus: a collection of genetic material packed inside a protein shell.
Once an RNA virus makes contact with a host, it starts to make new copies of itself that can go on to infect other cells.
RNA viruses, like the flu and measles, are more prone to changes and mutations compared with DNA viruses, such as herpes, smallpox, and human papillomavirus (HPV).
“In the world of RNA viruses, change is the norm. We expect RNA viruses to change frequently. That’s just their nature,” said Dr. Mark Schleiss, a pediatric infectious disease specialist and investigator with the Institute for Molecular Virology at the University of Minnesota.
SARS-CoV-2 is no exception, and over the past few months it has been mutating.
But the virus has mutated at a very slow pace. And when it does mutate, the new copies aren’t far off from the original virus.
“The sequences of the original isolates from China are very close to those in viruses circulating in the U.S. and the rest of the world,” said Dr. John Rose, a senior research scientist in the department of pathology at Yale Medicine who’s helping develop a COVID-19 vaccine.
- Forums
- ASX - By Stock
- Fly Time
"The Virus may never go away", WHO says. This could be...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 71720 | 94.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
94.5¢ | 10463 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 65720 | 0.940 |
3 | 31070 | 0.935 |
4 | 85753 | 0.930 |
2 | 9000 | 0.925 |
5 | 75776 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 10463 | 1 |
0.950 | 50000 | 2 |
0.955 | 64000 | 1 |
0.960 | 30220 | 3 |
0.965 | 44050 | 3 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |